Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis

The inhibition of pyrimidine biosynthesis by blocking the dihydroorotate dehydrogenase (DHODH) activity, the prime target of leflunomide (LEF), has been proven to be an effective strategy for rheumatoid arthritis (RA) treatment. However, a considerable proportion of RA patients are refractory to LEF...

Descrizione completa

Dettagli Bibliografici
Autori principali: Peres, RS, Santos, GB, Cecilio, NT, Jabor, VAP, Niehues, M, Torres, BGS, Buqui, G, Silva, CHTP, Costa, TD, Lopes, NP, Nonato, MC, Ramalho, FS, Louzada-Júnior, P, Cunha, TM, Cunha, FQ, Emery, FS, Alves-Filho, JC
Natura: Journal article
Lingua:English
Pubblicazione: BioMed Central 2017

Documenti analoghi